单腋窝切口反序内镜保乳乳头/皮肤乳房切除联合胸肌下假体乳房重建:88例初步手术的技术、临床结局与美学效果
本研究纳入68例患者共88例单腋窝切口反序内镜保乳头/皮肤乳房切除术联合胸肌下假体乳房重建,总体并发症率10.3%,主要并发症2.9%,中位随访24个月局部复发和远处转移率均为1.6%,92.1%患者获得医生评价良好或优秀的美学效果。
要点
- 总体并发症率10.3%,主要并发症2.9%,仅1例部分乳头乳晕复合体坏死。
- 中位随访24个月,局部复发和远处转移率均为1.6%。
- 92.1%患者获医生评价良好或优秀美学效果,85.3%患者自评乳房良好或优秀。
核心结论
- 单腋窝切口反序内镜保乳头乳房切除术联合胸肌下假体乳房重建安全、费用较低、效率高,具有可靠的中期肿瘤学安全性,适合的患者可获得良好美学效果。
研究设计与样本
- 单中心回顾性分析2020年5月至2022年5月接受单腋窝切口反序内镜保乳头/皮肤乳房切除术的患者,共68例患者88例手术,评估安全性和有效性,收集患者报告和医生报告的美学结果。
主要发现
- 总体并发症率10.3%;2.9%患者发生主要并发症,5例(7.4%)发生次要并发症;仅1例患者出现部分乳头乳晕复合体坏死。
- 中位随访24个月,局部复发率和远处转移率均为1.6%。
- 医生报告美学结果中92.1%患者达到良好或优秀;平均SCAR-Q评分82.07±8.86,85.3%患者自评乳房良好或优秀。
- 平均总费用5670.4±1351.3美元;平均总手术时间234.3±80.4分钟,成熟阶段平均手术时间172.55±41.29分钟。
- 累积和(CUSUM)图分析显示,外科医生约需18例手术才能显著缩短手术时间并降低并发症率。
临床怎么用
- 对于合适的候选患者,可采用单腋窝切口反序内镜保乳头乳房切除术联合胸肌下假体乳房重建,以获得良好美学效果和可靠的中期肿瘤学安全性。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single axillary incision reverse-order endoscopic nipple-sparing mastectomy overcomes the limitations of conventional endoscopic nipple-sparing mastectomy application. We introduce this technique and report the preliminary results of this study. METHODS: Patients who received single axillary incision reverse-order endoscopic nipple-/skin-sparing mastectomy from May 2020 to May 2022 were enrolled from a single institution. Data were analyzed to evaluate the safety and effectiveness of this technique. Patient-reported and surgeon-reported cosmetic outcomes were collected. RESULTS: In total, 68 patients who underwent 88 single axillary incision reverse-order endoscopic nipple-/skin-sparing mastectomy combined with subpectoral implant-based breast reconstruction were enrolled in the current study. The overall complication rate was 10.3%. In total, 2.9% of patients suffered from major complications, and 5 (7.4%) experienced minor complications. Only 1 patient experienced partial nipple-areola complex necrosis. During a median follow-up time of 24 months, the locoregional recurrence and distant metastasis rate was both 1.6%. In the surgeon-reported cosmetic results, 92.1% of patients achieved good or excellent results. The mean SCAR-Q scores were 82.07 ± 8.86, and 85.3% evaluated their breasts as good or excellent. The mean overall cost was 5,670.4 ± 1,351.3 USD. The total mean operation time and maturity-stage mean operation time were 234.3 ± 80.4 and 172.55 ± 41.29 min, respectively. According to cumulative sum plot analysis, approximately 18 cases were needed for surgeons to decrease their operation time significantly and complication rate. CONCLUSION: Single axillary incision reverse-order endoscopic nipple-sparing mastectomy is a safe, less expensive, and efficient surgical technique with reliable intermediate-term oncologic safety. For suitable candidates, the technique with subpectoral implant-based breast reconstruction can provide a good cosmetic outcome.
引用
- Yang H, Liang F, Xie Y, et al. Single axillary incision reverse-order endoscopic nipple/skin-sparing mastectomy followed by subpectoral implant-based breast reconstruction: Technique, clinical outcomes, and aesthetic results from 88 preliminary procedures. Surgery. 2023. PMID: 37422354. doi:10.1016/j.surg.2023.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。